2m 2m 2m 2m 2m 2m 2m
Ardent Health (ARDT)
NYSE
$9.18+$0.15 (+1.61%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.3BMarket Cap
- -30.22%1-Year Change
- Medical Care FacilitiesIndustry
Ardent Health (ARDT)
$9.18+$0.15 (+1.61%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 6.3B +6.01% | 6.0B N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 6.3B +6.01% | 6.0B N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 155.7M +6.44% | 146.3M N/A | |
Total Operating Expenses | 6.0B +7.76% | 5.6B N/A | |
Operating Profit | 286.4M -21.13% | 363.1M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -1.1M -88.42% | -9.5M N/A | |
Interest Income and Expense and Net | -1.1M -88.42% | -9.5M N/A | |
Total Nonoperating Income and Expense | 23.3M -11.21% | 26.3M N/A | |
Income before Taxes | 286.4M -21.13% | 363.1M N/A | |
Income Taxes | 56.2M -11.25% | 63.4M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 135.8M -35.43% | 210.3M N/A | |
Net Income from Continuing Operations Applicable to Common | 286.4M -21.13% | 363.1M N/A | |
Basic EPS and Net Income | 0.96 -39.62% | 1.59 N/A | |
Diluted EPS and Net Income | 0.96 -39.24% | 1.58 N/A | |
Basic Weighted Average Shares | 140.8M +6.28% | 132.4M N/A | |
Diluted Weighted Average Shares | 141.5M +6.56% | 132.7M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 709.6M +27.45% | 556.8M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 709.6M +27.45% | 556.8M N/A | |
Total Current Assets | 2.1B +12.34% | 1.8B N/A | |
Accumulated Depreciation | 1.1B +7.69% | 989.5M N/A | |
Property and Plant and Equipment and Net | 935.8M +8.57% | 861.9M N/A | |
Total Long-Term Assets | 111.7M -21.88% | 143.0M N/A | |
Total Assets | 5.3B +6.74% | 5.0B N/A | |
Income Taxes Payable | N/A N/A | 60.2M N/A | |
Total Short-Term Debt | 23.4M +153.89% | 9.2M N/A | |
Total Current Liabilities | 1.0B +10.70% | 945.4M N/A | |
Total Long-Term Debt | 1.1B -0.92% | 1.1B N/A | |
Total Long-Term Liabilities | 76.6M +120.87% | 34.7M N/A | |
Total Liabilities | 3.6B +4.99% | 3.4B N/A | |
Retained Earnings | 501.6M +37.13% | 365.8M N/A | |
Total Stockholders Equity | 1.3B +13.83% | 1.1B N/A | |
Total Shares Outstanding | 142.9M +0.08% | 142.7M N/A | |
Cash Flow | |||
Cash from Operating Activities | 470.5M +49.36% | 315.0M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | -214.2M -2.83% | -220.5M N/A | |
Dividends Paid | N/A N/A | 0 N/A | |
Cash from Financing Activities | -103.5M -519.87% | 24.6M N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | 4.53% N/A | N/A N/A | |
Return on Assets | 2.65% N/A | N/A N/A | |
Return on Equity | 11.23% N/A | N/A N/A | |
Revenue Growth | 6.01% N/A | N/A N/A | |
Current Ratio | 1.97 N/A | N/A N/A | |
Cash Ratio | 0.68 N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.85 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.21 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow